Rituximab in patients with refractory autoimmune hemolytic anemia

被引:0
|
作者
Dierickx, Daan [1 ]
Verhoef, Gregor [1 ]
Delannoy, Andre [2 ]
机构
[1] Katholieke Univ Leuven Hosp, Dept Hematol, B-3000 Louvain, Belgium
[2] Clin Univ St Luc, Hop Jolimont Haine St Paul & Clin, B-1200 Brussels, Belgium
关键词
COLD AGGLUTININ DISEASE; THERAPY;
D O I
10.1007/s00277-010-1117-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:985 / 986
页数:2
相关论文
共 50 条
  • [21] A case report of refractory warm autoimmune hemolytic anemia treated with plasmapheresis and rituximab
    Aglieco, Fabio
    Manickaratnam, Srimathi
    Bona, Robert
    Kaplan, Andre A.
    THERAPEUTIC APHERESIS AND DIALYSIS, 2008, 12 (02) : 185 - 189
  • [22] The successful treatment of refractory autoimmune hemolytic anemia with rituximab in a patient with chronic lymphocytic leukemia
    Pamuk, Gulsum Emel
    Turgut, Burhan
    Demir, Muzaffer
    Tezcan, Fatma
    Vural, Ozden
    AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (08) : 631 - 633
  • [23] Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia
    Francisco Javier Peñalver
    Alberto Alvarez-Larrán
    Jose Luis Díez-Martin
    Laura Gallur
    Isidro Jarque
    Dolores Caballero
    Joaquín Díaz-Mediavilla
    Rosalía Bustelos
    María Jesús Fernández-Aceñero
    José Rafael Cabrera
    Annals of Hematology, 2010, 89 : 1073 - 1080
  • [24] Alemtuzumab induced complete remission of autoimmune hemolytic anemia refractory to corticosteroids, splenectomy and rituximab
    Cheung, Winnie W.
    Hwang, Gloria Y.
    Tse, Eric
    Kwong, Yok-Lam
    HAEMATOLOGICA, 2006, 91 : 42 - 43
  • [25] Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia
    Javier Penalver, Francisco
    Alvarez-Larran, Alberto
    Luis Diez-Martin, Jose
    Gallur, Laura
    Jarque, Isidro
    Caballero, Dolores
    Diaz-Mediavilla, Joaquin
    Bustelos, Rosalia
    Jesus Fernandez-Acenero, Maria
    Rafael Cabrera, Jose
    ANNALS OF HEMATOLOGY, 2010, 89 (11) : 1073 - 1080
  • [26] Bortezomib and daratumumab in refractory autoimmune hemolytic anemia
    McGlothlin, John
    Abeykoon, Jithma
    Al-Hattab, Eyad
    Ashrani, Aneel A.
    Elliott, Michelle
    Hook, C. Christopher
    Pardanani, Animesh
    Pruthi, Rajiv
    Sridharan, Meera
    Wolanskyj, Alexandra
    Rouse, Rachelle
    Go, Ronald
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (10) : E263 - E265
  • [27] Severe refractory autoimmune hemolytic anemia with both warm and cold autoantibodies: Complete response with rituximab
    Gupta, Shilpi
    Varma, Seema
    Szerszen, Anita
    Nakhl, Fadi
    Gottesman, Aaron
    Forte, Frank J.
    Dhar, Meeko
    BLOOD, 2007, 110 (11) : 76B - 76B
  • [28] Activity of rituximab monotherapy in refractory splenic marginal zone lymphoma complicated with autoimmune hemolytic anemia
    Fabbri, Alberto
    Gozzetti, Alessandro
    Lazzi, Stefano
    Lenoci, Mariapia
    D'Amuri, Alessandro
    Leoncini, Lorenzo
    Lauria, Francesco
    CLINICAL LYMPHOMA & MYELOMA, 2006, 6 (06): : 496 - 499
  • [29] ABATACEPT FOR MANAGEMENT OF REFRACTORY AUTOIMMUNE HEMOLYTIC ANEMIA
    de la Maza, Michelina
    Shah, Sanjay
    Ahmad-Nabi, Maria
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [30] Daratumumab for refractory warm autoimmune hemolytic anemia
    Jain, Ankur
    Gupta, D. K.
    ANNALS OF HEMATOLOGY, 2021, 100 (05) : 1351 - 1353